Non-covalent inhibitors of the 20S proteasome

被引：1

作者：

García-Echeverría, C ^{[1
]}

Imbach, P ^{[1
]}

Roesel, J ^{[1
]}

Fuerst, P ^{[1
]}

Lang, M ^{[1
]}

Guagnano, V ^{[1
]}

Noorani, M ^{[1
]}

Zimmermann, J ^{[1
]}

Furet, P ^{[1
]}

机构：

[1] Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland

来源：

CHIMIA | 2003年 / 57卷 / 04期

关键词：

antitumor agents; drug design; enzyme inhibitors; peptidomimetic;

D O I：

10.2533/000942903777679415

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Peptidomimetics have been commonly used as lead compounds to design inhibitors with high affinity and specificity for a particular enzyme. The discovery that a 2-aminobenzylstatine derivative originally designed to target an aspartyl protease was able to inhibit specifically and non-covalently the chymotrypsin-like activity of the 20S proteasome represented a unique starting point for our medicinal chemistry endeavor for this target. Utilizing a structure-based design approach, we have been able to improve the potency of this new class of proteasome inhibitors without affecting its in vitro selectivity profile.

引用

页码：179 / 181

页数：3

共 50 条

[21] Capillary electrophoresis for screening of 20S proteasome inhibitors
Chen, Wenjing
Mou, Ke
Xu, Bo
Ling, Xiaomei
Cui, Jingrong
Xu, Ping
ANALYTICAL BIOCHEMISTRY, 2009, 394 (01) : 62 - 67
[22] Covalent and non-covalent reversible proteasome inhibition
Beck, Philipp
Dubiella, Christian
Groll, Michael
BIOLOGICAL CHEMISTRY, 2012, 393 (10) : 1101 - 1120
[23] Macrocyclic peptide aldehyde inhibitors of the 20S proteasome
Strater, Zack M.
Wilson, David
Wu, Julia
Gotz, Marion G.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
[24] The 20S proteasome
Zwickl, P
PROTEASOME-UBIQUITIN PROTEIN DEGRADATION PATHWAY, 2002, 268 : 23 - 41
[25] Identification of Potent and Selective Non-covalent Inhibitors of the Plasmodium falciparum Proteasome
Li, Hao
Tsu, Christopher
Blackburn, Christopher
Li, Gang
Hales, Paul
Dick, Lawrence
Bogyo, Matthew
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (39) : 13562 - 13565
[26] Investigation of HDAC and 20S Proteasome Inhibitors from Cyanobacteria
Martins, Joana
Campos, Alexandre
Leao, Pedro N.
Vasconcelos, Vitor
MARINE DRUGS, 2020, 18 (01)
[27] Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitors
Marechal, Xavier
Pujol, Anais
Richy, Nicolas
Genin, Emilie
Basse, Nicolas
Reboud-Ravaux, Michele
Vidal, Joelle
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 52 : 322 - 327
[28] Recent Advances in the Identification and Development of 20S Proteasome Inhibitors
Garcia-Echeverria, Carlos
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (03) : 247 - 259
[29] Assembly of the 20S proteasome
Kunjappu, Mary J.
Hochstrasser, Mark
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2014, 1843 (01): : 2 - 12
[30] 20S proteasome biogenesis
Krüger, E
Kloetzel, PM
Enenkel, C
BIOCHIMIE, 2001, 83 (3-4) : 289 - 293

← 1 2 3 4 5 →